Graphite Bio
@GraphiteBio
Creating a future where the word 'incurable' no longer exists. Community guidelines: http://bit.ly/3c5Pztz
Bunları beğenebilirsin
What an incredible week at #ASH22! Thank you @ASH_hematology for a fantastic conference and the city of New Orleans for your hospitality. We are grateful for the opportunity to share our research and our passion to cure disease through the power of #GeneEditing.
Today at #ASH22, visit the poster session 6-8 p.m. in Hall D to hear our genomics lead Sebastian Treusch, Ph.D., describe our single-cell #RNA sequencing method to assess gene correction outcomes in patients with #SickleCell. Read more here: bit.ly/3HJ5sEb
This holiday season, our team came together to support the #SickleCell Community Advisory Council of Northern California's annual gift drive for #SCD patients being cared for by hospitals in the #SanFrancisco #BayArea. Honored to support our local community
Heading to #ASH22 this weekend? Get an early start by reading the abstracts published online in Blood, including our abstract detailing our gene replacement strategy for beta-thalassemia. #GeneEditing bit.ly/3Fvammr
Thanks to #EvercoreISI's Liisa Bayko for hosting a #FiresideChat with our CFO Alethia Young during the 5th Annual #HealthCONx Conference. ICYMI, the replay is available here: bit.ly/3UkbFsB. #GeneEditing
This week, our SVP, Development Darren Hart and VP, Clinical Development Wes Miller will speak at the 3rd Annual #CRISPR 2.0 Summit about planning and preparing for clinical development of #GeneEditing therapies. Learn more: crispr-conference.com.
On this #NationalFamilyHealthHistoryDay, find out how learning your family's health history can help you discover your genomic heritage and risks, and guide you in making important health and lifestyle choices. Learn more: bit.ly/2XQbHge
In honor of #Thanksgiving, we celebrated with our annual company tradition: Pie² - pizza pie and dessert pie! Wishing all those who celebrate a happy, healthy holiday.
Our Research and Early Development team recently took a little break to enjoy some bowling, soak up the sun and spend time together. #WorkHardPlayHard - that's how we roll.
Attending the Biomanufacturing World Summit in San Diego? Don't miss our Chief Technical Officer Jerry Cacia in the closing panel discussion about how the #biomanufacturing community can maximize its impact on the future of medicine. #BMWS22
Today we announced business updates and our third quarter 2022 financial results: bit.ly/3Tqtiqh $GRPH #Biotech
We look forward to sharing our #GeneEditing research supporting our #BetaThalassemia and #SickleCell programs at @ASH_hematology #ASH22 bit.ly/3DRKpeR
Our People Operations Partner, Phoebe Hamilton, is inspired to come to work every day thanks to our team's passion and excitement as they aim to develop potential cures for serious diseases, starting with #SickleCell.
In honor of #NationalFamilyCaregiversMonth, we are celebrating the incredible #SickleCell caregivers for the vital role they play in the #SCD community. bit.ly/3DRrEJJ #NFCMonth #CaregivingHappens
#HappyHalloween from the Graphite Bio team! From cell fitness to nucleotides to clones of our CEO, famous musicians and cereal killers, our team's creativity always shines when we get together. Have a spooktacular #Halloween!
Ever wonder how we came up with the name nula-cel for our investigational #GeneEditing therapy? It turns out there is important meaning behind the different components of the name!
Our CEO Dr. Josh Lehrer connected with @biospace to discuss the need to address the underlying genetic cause of #SickleCell and how we’re aiming to do it. Read about our unique #GeneEditing approach to correct the misspelling in the DNA that causes #SCD. bit.ly/3ziazpE
biospace.com
Gene Therapy could Change the Goalpost in Sickle Cell Disease
While worthy advances have recently been made in sickle cell disease, companies such as Graphite Bio, bluebird bio, Vertex Pharmaceuticals and Editas Medicine have loftier ambitions.
According to our Sr. Manager, Program Alliance and Management, David Tsai, "our sense of urgency and mission to bring innovative #SCD treatments to people who need it most" is what inspires him to come to work everyday.
.@IBDinvestors highlights the need to develop treatments for genetic diseases like #SickleCell, quoting our CEO Dr. Josh Lehrer on how curing #SCD requires addressing more than pain & the importance of our efforts to develop a definitive cure. #GeneEditing bit.ly/3VLEGzi
investors.com
Ready Or Not, New Gene-Editing Drugs May Be Coming Soon
Despite enthusiasm in some camps, the risk of potential cures continues to cloud market projections.
We love spending time with our founders! Thank you to Dr. Matthew Porteus from @StanfordMed for sharing your journey as a #GeneEditing pioneer and the creation of Graphite Bio. We are inspired and privileged to have you as part of the team.
United States Trendler
- 1. Good Saturday 20.4K posts
- 2. Emiru 10.1K posts
- 3. Dodgers 274K posts
- 4. Ohtani 232K posts
- 5. #dominATE_celebrATE 43.8K posts
- 6. World Series 64.4K posts
- 7. Massie 34.9K posts
- 8. Babe Ruth 3,753 posts
- 9. Carson Beck 17K posts
- 10. #HeartofTaehyung 45.2K posts
- 11. Louisville 29.1K posts
- 12. TOP CALL 9,879 posts
- 13. Sam Harris 1,294 posts
- 14. Nebraska 17.6K posts
- 15. FDV 5min 3,003 posts
- 16. Talus 15.3K posts
- 17. TwitchCon 26.3K posts
- 18. AI Alert 8,582 posts
- 19. George Santos 92.2K posts
- 20. FDV Surge Alert N/A
Bunları beğenebilirsin
-
Scribe Therapeutics
@scribetx -
Feng Zhang
@zhangf -
Beam Therapeutics
@BeamTx -
Caribou Biosciences
@CaribouBio -
John Evans
@john_evans3 -
Editas Medicine
@editasmed -
Moleculin Biotech
@moleculinbio -
David R. Liu
@davidrliu -
BioBoyScout
@BioBoyScout -
Nicole M. Gaudelli
@NicoleGaudelli -
Tessera Therapeutics
@TesseraTx -
CRISPR Therapeutics
@CRISPRTX -
Cold Spring Harbor Laboratory
@CSHL -
Ginkgo Bioworks
@Ginkgo -
CRISPR News 🧬
@CRISPR_News
Something went wrong.
Something went wrong.